Makers and distributors of APIs (active pharmaceutical ingredients) will have to track their products throughout the supply chain and meet rules on cold chain transport and outsourcing under revised guidance from the European Commission.
Aarti Drugs says the US FDA has not provided details of observations that earned its E-22 facility in Tarapur, India an import ban.
Capsugel will invest $25m (€22m) to expand production of vegetarian-friendly drug and food supplement capsules.
Sourcing human beta cells may soon no longer be a challenge for AstraZeneca diabetes researchers thanks to a new partnership with stem cell scientists at Harvard University.
Biohaven Pharmaceutical has created a melt in the mouth anxiety drug using formulation technology licensed from Catalent.
Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.
Dispatches from DCAT
The European pharma market isn’t likely to deliver much growth over the next five years as generic...
More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...
The FDA has tested hundreds of creatively named bogus supplements and found they contain hidden APIs. Take...